![Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease (4th International Symposium, Munich, October 1992) || Serum Cholesterol Lowering by Dietary Sitostanol Is Associated with Reduced Absorption and Synthesis of Cholesterol and Decreased Transport of LDL Apoprotein B in Men with Type II Diabetes]()
Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease (4th International Symposium, Munich, October 1992) || Serum Cholesterol Lowering by Dietary Sitostanol Is Associated with Reduced Absorption and Synthesis of Cholesterol and Decreased Transport of LDL Apoprotein B in Men with Type II DiabetesGotto Jr., A.M.; Mancini, M.; Richter, W.O.; Schwandt, P. · 1993